CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 811 - 820 of 842
Study Number Lead Group Study Title CIRB Study Status
NRG-CC004 NRG Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire In Women With Breast or Gynecologic Cancer Cancer Prevention and Control CIRB Available to Open
MAY2015-05-01 CLO-Mayo Clinic Randomized, double-blind, placebo-controlled trial of Meriva® (curcuminoids) as a candidate chemoprevention agent for gastric carcinogenesis Cancer Prevention and Control CIRB Available to Open
WF-1801 NCORP-Wake Forest University A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy Cancer Prevention and Control CIRB Available to Open
E1Q11 ECOG EROS: Engendering Reproductive Health within Oncologic Survivorship Cancer Prevention and Control CIRB Available to Open
EAQ171CD ECOG-ACRIN Implementing a Virtual Tobacco Treatment in Community Oncology Practices: “Smoke Free Support Study 2.0” Cancer Prevention and Control CIRB Available to Open
WF-1802 NCORP-Wake Forest University Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW) Cancer Prevention and Control CIRB Available to Open
A191402CD Alliance Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men Cancer Prevention and Control CIRB Available to Open
URCC-16092 NCORP-University of Rochester Cancer Center Phase II Study of Exercise and Low-Dose Ibuprofen for Cognitive Impairment in Colorectal Cancer Patients Receiving Chemotherapy Cancer Prevention and Control CIRB Available to Open
UAZ2015-05-02 CLO-University of Arizona M4OC-Prevent: Metformin for Oral Cancer Prevention Cancer Prevention and Control CIRB Available to Open
MAY2016-07-01 CLO-Mayo Clinic Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis Cancer Prevention and Control CIRB Available to Open
Displaying 811 - 820 of 842